Skip to main content

Table 4 Factors associated with costs incurred by patients during the last two months of treatment in Rio de Janeiro, using income per activity reported by participant to value a productive hour (USD 2013)

From: Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services

Variables

Number in each category with direct costs

Direct costs, mean (SD) N = 85b

P valuea

Indirect costs, mean (SD) N = 126

P valuea

Total costs, mean (SD) N = 126

P-valuea

Sexb

       

 Female

32

79 (126)

0.313

355 (1,981)

0.892

127 (145)

0.263

 Male

53

107 (161)

 

318 (1,040)

 

169 (236)

 

Age

       

  < 43 years

41

105 (165)

0.527

289 (998)

0.743

167 (251)

0.451

  > = 43 years

44

88 (131)

 

375 (1834)

 

139 (139)

 

Treatment history

       

 New case

71

101 (155)

0.544

373 (1,628)

0.524

153 (217)

0.952

 Retreatment

14

80 (116)

 

159 (299)

 

150 (157)

 

Residence

       

 Urban

56

88 (152)

0.351

258 (978)

0.386

135 (213)

0.166

 Peri-urban

29

114 (140)

 

500 (2,193)

 

190 (187)

 

Treatment type

       

 SAT

52

110 (165)

0.379

560 (49)

0.216

170 (256)

0.333

 Facility-DOT

29

93 (137)

 

126 (185)

 

154 (142)

 

 Community-DOT

4

52 (104)

 

39 (49)

 

81 (122)

 

Socioeconomic statusc

       

 A/B (median family income USD 4288.4-USD 1228.7)

18

60 (108)

0.128

68 (137)

0.042

98 (121)

0.099

 C/D/E (median family income USD 780.1-USD 359.2)

64

111 (160)

 

428 (1,703)

 

175 (227)

 
  1. Abbreviations: SAT self-administered therapy; DOT directly observed therapy; SD standard deviation
  2. *from independent t-test
  3. bAmong 126 patients, 85 patients or accompanying persons declared direct costs
  4. cmissing information for 3 participants
  5. Bold numbers highlight significant p-values.